Работы, на которые ссылается эта работа

Работ: 64

Работа: Sumac ( <i>Rhus coriaria L.</i> ) and Human Metabolic Health: A Systematic Review and Meta‐Analysis

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
PRISMA-P Group, David Moher, Larissa Shamseer +6
Статья2015Цитирований: 8
ABI
Meta-analysis in clinical trials
Rebecca DerSimonian, Nan M. Laird
Статья1986Цитирований: 8
ABI
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
Zobair M. Younossi, Aaron B. Koenig, Dinan Abdelatif +3
Обзорная статья2015Цитирований: 7
ABI
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference, Henry N. Ginsberg, Ian Graham +23
Обзорная статья2017Цитирований: 4
ABI
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
Irene Stratton
Статья2000Цитирований: 4
ABI
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher, Christopher D. Byrne, Amedeo Lonardo +2
Обзорная статья2016Цитирований: 3
ABI
Variance imputation for overviews of clinical trials with continuous response
Dean Follmann, Paul Elliott, Il Suh +1
Статья1992Цитирований: 3
ABI
Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
The Look AHEAD Research Group
Статья2013Цитирований: 3
ABI
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C Baigent, Colin Baigent, Lisa Blackwell +8
Обзорная статья2010Цитирований: 2
ABI
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
Michael G. Silverman, Brian A. Ference, Kyungah Im +5
Обзорная статья2016Цитирований: 2
ABI
Pharmacological and Antioxidant Activities of Rhus coriaria L. (Sumac)
Halima Alsamri, Khawlah Athamneh, Gianfranco Pintus +2
Обзорная статья2021Цитирований: 2
ABI
Antioxidant activity and phenolic composition of sumac (Rhus coriaria L.) extracts
Müberra Koşar, Berrin Bozan, Feral Temelli +1
Статья2006Цитирований: 2
ABI
Anti-Ischemic Activity and Endothelium-Dependent Vasorelaxant Effect of Hydrolysable Tannins from the Leaves of<i>Rhus coriaria</i>(Sumac) in Isolated Rabbit Heart and Thoracic Aorta
Giangiacomo Beretta, Giuseppe Rossoni, Natale Alfredo Santagati +1
Статья2009Цитирований: 2
ABI
Rhus coriaria suppresses angiogenesis, metastasis and tumor growth of breast cancer through inhibition of STAT3, NFκB and nitric oxide pathways
Hussain El Hasasna, Alaaeldin Saleh, Halima Al Samri +9
Статья2016Цитирований: 2
ABI
Obesity, Oxidative Stress, Adipose Tissue Dysfunction, and the Associated Health Risks: Causes and Therapeutic Strategies
Prasenjit Manna, Sushil K. Jain
Обзорная статья2015Цитирований: 2
ABI
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies, David A. D’Alessio, Judith Fradkin +7
Статья2018Цитирований: 2
ABI
Ginger on Human Health: A Comprehensive Systematic Review of 109 Randomized Controlled Trials
Nguyễn Hoàng Anh, Sun Jo Kim, Nguyen Phuoc Long +11
Обзорная статья2020Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI